Benjamin D. Stevens

Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors

Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson et al. · Journal of Medicinal Chemistry · 2011 · 134 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of (<i>S</i>)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus

Jeffrey A. Pfefferkorn, Angel Guzmán-Pérez, John Litchfield et al. · Journal of Medicinal Chemistry · 2011 · 115 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification

Whitney M. Nolte, Jean‐Philippe Fortin, Benjamin D. Stevens et al. · Nature Chemical Biology · 2014 · 87 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Immobilized Enzymes as Catalytically-Active Tools for Nanofabrication

Chang‐Hyun Jang, Benjamin D. Stevens, Paul R. Carlier et al. · Journal of the American Chemical Society · 2002 · 46 citations

Natural Sciences, Biotechnology, Chemistry +17

The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus

Angel Guzmán-Pérez, Jeffrey A. Pfefferkorn, Esther C.Y. Lee et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 40 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12